Price: $ 1295
BMI View: Angola's economy is booming, making progress in diversifying its economy from its oil-base. Increased foreign investment in natural resources is bringing with it increased demand for healthcare services - as such, we forecast that the pharmaceuticals and healthcare markets will outperform the economy as a whole. But investment in healthcare is held back by many factors. Counterfeit and substandard drugs are a continual problem, and while the basic drugs produced by state-owned Nova Angomédica will go some way to reducing Angola's reliance on imports, the state still needs to improve its import controls and drug distribution network. Part of the problem is that there is little information about Angola's drug imports and exports - meaning that it is hard to calculate the potential scale of ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/268303.html
No comments:
Post a Comment